Jia Youduo, Gu Yunfei, Wang Lijun, Jiang Nan, Yu Xiumei, Tian Hu
Nephrology Department, Liaocheng Traditional Chinese Medicine Hospital, Liaocheng, China.
College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
J Tissue Viability. 2025 Feb;34(1):100854. doi: 10.1016/j.jtv.2025.100854. Epub 2025 Jan 4.
Diabetic nephropathy (DN) is a severe complication of diabetes mellitus and a leading cause of end-stage renal disease worldwide. Understanding trends in experimental research on DN is crucial for advancing knowledge and clinical management.
This study aimed to explore current trends in DN related experimental research, utilizing CiteSpace, VOSviewer, and Bibliometrix to identify key contributors, influential countries, and noteworthy topics. The objective was to provide valuable insights for healthcare professionals and researchers in the field.
Relevant publications from the Web of Science Core Collection Science Citation Index Expanded were retrieved for the period between 2018 and 2024. CiteSpace, VOSviewer, and Bibliometrix were employed for data analysis, including identifying top authors, institutions, countries, keywords, co-cited authors, journals, references, and research trends.
A total of 1501 relevant articles were included in the study. DN related experimental research exhibited an upward trend, reaching its peak in 2023. Key contributors such as Kretzler Matthias, Li Ping, and Rossing Peter emerged. China, the United States and Japan have the most publications. Keyword analysis revealed "activated protein kinase" as the most central keyword, while "diabetic nephropathy" had the highest citation rate. Recent focus shifted towards keywords like "Traditional Chinese Medicine" and "molecular docking."
This bibliometric analysis provides insights into trends in experimental research on DN from 2018 to 2024. Notable contributors and influential countries were identified, emphasizing global collaboration. Key topics demonstrate diverse approaches and emerging trends, supporting informed decision-making and innovation in combatting DN and enhancing patient outcomes.
糖尿病肾病(DN)是糖尿病的一种严重并发症,也是全球终末期肾病的主要原因。了解DN实验研究的趋势对于推动知识进步和临床管理至关重要。
本研究旨在利用CiteSpace、VOSviewer和Bibliometrix探索DN相关实验研究的当前趋势,以确定关键贡献者、有影响力的国家和值得关注的主题。目的是为该领域的医疗专业人员和研究人员提供有价值的见解。
检索了2018年至2024年期间Web of Science核心合集科学引文索引扩展版中的相关出版物。使用CiteSpace、VOSviewer和Bibliometrix进行数据分析,包括确定顶级作者、机构、国家、关键词、共被引作者、期刊、参考文献和研究趋势。
该研究共纳入1501篇相关文章。DN相关实验研究呈上升趋势,在2023年达到峰值。出现了如克雷茨勒·马蒂亚斯、李平、罗辛·彼得等关键贡献者。中国、美国和日本的出版物最多。关键词分析显示,“活化蛋白激酶”是最核心的关键词,而“糖尿病肾病”的被引率最高。近期的研究重点转向了“中药”和“分子对接”等关键词。
这项文献计量分析提供了对2018年至2024年DN实验研究趋势的见解。确定了显著贡献者和有影响力的国家,强调了全球合作。关键主题展示了多样化的方法和新兴趋势,为抗击DN和改善患者结局的明智决策和创新提供了支持。